The Deal Register
Database › M&A › Sun Pharma Canada Inc. Acquires Commercial Rights to LEVULAN®…

M&A

Sun Pharma Canada Inc. Acquires Commercial Rights to LEVULAN® KERASTICK®

Lane
M&A
Announced
12 Nov 2025
Province
Ontario
Industry
Healthcare & life sciences
Status
Announced
What the filing says
Sun Pharma, a global pharmaceutical company with a growing portfolio of Innovative Medicines, today announced it acquired, at no cost, the commercial sales rights to LEVULAN KERASTICK (aminolevulinic acid hydrochloride) in Canada from Clarion Medical Technologies.
Source

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe